Vietnamese hospital receives Japanese cell therapy technology for cancer and chronic disease treatment

Résumé détaillé

Tam Anh General Hospital has completed an exclusive technology transfer from Japan's Grandsoul Medical Group covering immune cell and stem cell technologies being explored for treatment of cancer and chronic diseases.

Vietnam's Tam Anh General Hospital Group and Japan's Grandsoul Medical Group have completed the transfer of natural killer (NK) immune cell and mesenchymal stem cell (MSC) technologies, marking a new step in medical cooperation between the two countries.

Developed by the Grandsoul Research Institute for Immunology in Nara, Japan, two technologies being transferred to Tam Anh hospital are autologous NK therapy, and autologous MSC therapy.

The first one includes the protocols of cell activation, expansion, evaluation and preparation for cancer treatment, while the second includes adipose tissue processing, cell isolation, expansion and evaluation.

The completion of the technology transfer was announced on Nov. 9 during a visit to Japan by a high-level Vietnamese delegation from Nov. 8 to 11. The ceremony was witnessed by Party General Secretary and President To Lam and senior officials from both countries.

Tam Anh is one of the first institutions in Vietnam selected, on an exclusive basis, for the comprehensive transfer of these core technologies from leading Japanese group Grandsoul. The transfer opens up new opportunities for treatment of cancer and chronic diseases and improving the health of people in Vietnam.

Mastering cell therapy (stem cells and immune cells) to treat cancer, chronic diseases and intractable diseases is a national strategy approved by the Government for implementation from 2026 to 2030. This comprehensive, in-depth transfer is good news, as it makes this the first strategic technology realized ahead of schedule in Vietnam.

Ngo Thi Ngoc Hoa (front row, 3rd from left), general director of Tam Anh General Hospital Group, and Tsujimura Takahiro, director of the Grandsoul Nara Institute of Immunology Research, exchange documents marking the completion of the exclusive technology transfer. Photo by VNA

According to Tam Anh, the technologies are intended for use across its five facilities in Ho Chi Minh City and Hanoi, which together handle more than 10,000…

Début de l'article, extrait de VnExpress International. Pour lire la suite, ouvrez l'article chez le média.